Environmental Factors as Determinants of Severity of SCD in Nigeria
Journal Title: Haematology International Journal - Year 2018, Vol 2, Issue 4
Abstract
Sickle cell anaemia (SCA) is a chronic blood disorder characterized by red blood cells that assume an abnormal sickle shape when deoxygenated and may block different areas of the microcirculation causing ischaemia in various organs. This study was carried out to find out the roles of environmental factors in determining the clinical severity of SCA in Nigeria. 1.1. Subjects and Methods: This was a multicentre cross-sectional study amongst 261 SCA subjects in seven tertiary health care centres in Nigeria. After obtaining each Institution’s ethics and research committee approval, a pretested structured questionnaire was administered to respondents by trained research assistants. Subjects were asked questions on number of crises, number of transfusions and number of hospitalizations in the previous one year 1.2. Results: Jos Centre had the highest frequency (30%) of those who had more than three crises in the previous one year while Calabar (9.3%) and Lagos (10%) had the least. Frequency of more than three transfusions was highest in Maiduguri (6.3%) and Abuja(6.3%) respectively with Lagos, Enugu and Calabar centres in the southern part of Nigeria recording no transfusion during the study period. Calabar centre had the highest number of people (90.6%) who had not been transfused before and those who had not been hospitalized (71.9%). Maiduguri (16.7%) and Jos (15%) topped the number of those who had been hospitalized for more than three times while Lagos (0%) and Calabar (3.1) had the least. 1.3. Conclusion: Altitude and hot weather are major environmental factors that contribute to the clinical severity of SCD in Nigeria.
Authors and Affiliations
Tamunomieibi Wakama
Keywords
Related Articles
- EP ID EP404335
- DOI 10.23880/hij-16000132
- Views 132
- Downloads 0
Extramedullary Multiple Myeloma in the Kidney: A Case Report
Extramedullarymyeloma (EMM) is defined by the presence of plasma cells outside the bone marrow in a patient with multiple myeloma (MM). EMM is classified under four headings as bone-associated plasmacytoma, extramedullar...
Hemochromatosis Gene Mutation and Erythrocytosis
In a patient group presenting with either increased Hgb level or high RBC count HFE gene mutations occured in two-third of the patients. The explanation for this phenomenon is still missing. These patients had normal ery...
Herpes Zoster Infection in Patient with Chronic Myeloid Leukemia on Imatinib
Varicella-zoster virus is a member of the Herpesviridae family. It can cause chickenpox and Herpes zoster infection (shingles). The latter is an acute, cutaneous infection caused by reactivation of a primary varicella in...
Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
1.1. Background: A significant survival prolongation was recently reported by adding idelalisib to rituximab (IR) compared with rituximab (R) in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL). No...
Multiple Myeloma in Cameroon: Clinico-Biological Characteristics of Patients; an Experience from Douala General Hospital
1.1. Background: Multiple myeloma is the most common haematological malignancy among blacks. There is paucity of data on this subject in Africa in general and Cameroon in Cameroon. This study aims at describing initial c...